Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers

Biochemical Pharmacology
Hiroshi Yamazaki, T Shimada

Abstract

Human liver microsomes had about 8-fold higher 7-hydroxylation activities for S-warfarin than for R-warfarin. Activities of racemic warfarin 7-hydroxylation by liver microsomes of 35 human samples correlated more closely with those of S-warfarin 7-hydroxylation (r = 0.95) than with those of R-warfarin 7-hydroxylation (r = 0.69). The correlation coefficient between R-warfarin 7-hydroxylation and 7-ethoxyresorufin O-deethylation activities was 0.73 in these human samples, suggesting that R- and S-warfarin enantiomers are catalyzed by different forms of human cytochrome P450 (P450 or CYP) enzymes. Anti-CYP2C9 antibodies inhibited completely the 7-hydroxylation of S-warfarin, but not R-warfarin, catalyzed by human liver microsomes, while anti-CYP1A2 inhibited R-warfarin 7-hydroxylation by about 70%. Interestingly, the racemic warfarin 7-hydroxylation activities (turnover numbers of 1.6 +/- 1.0 pmol/min/mg protein in 35 human samples) were found to be low compared with the S-warfarin 7-hydroxylation activities (4.1 +/- 2.5 pmol/min/mg protein), indicating that R-warfarin may have affected the CYP2C9-dependent S-warfarin 7-hydroxylation activities when racemic warfarin was used as a substrate. Several P450 inhibitors, as well as R-wa...Continue Reading

References

Jul 1, 1991·Chemical Research in Toxicology·F P Guengerich, T Shimada
Jan 1, 1981·Methods in Enzymology·L S KaminskyF P Guengerich
Oct 1, 1995·Clinical Pharmacology and Therapeutics·C TransonP Dayer
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Jul 1, 1994·Clinical Pharmacokinetics·K T KivistöU Klotz
Aug 1, 1994·Pharmacogenetics·P B Watkins
Apr 1, 1994·Toxicology and Applied Pharmacology·J R HalpertM A Correia
Oct 1, 1993·Clinical Pharmacology and Therapeutics·M GrindJ Aberg
Aug 1, 1993·Trends in Pharmacological Sciences·D J BickettJ O Miners
Aug 15, 1993·Archives of Biochemistry and Biophysics·E M GillamF P Guengerich
Mar 24, 1993·JAMA : the Journal of the American Medical Association·P K HonigL R Cantilena
Mar 24, 1993·Biochemical Pharmacology·K BrøsenS Loft
Jan 1, 1995·Drug Metabolism Reviews·M Spatzenegger, W Jaeger
Jan 1, 1996·European Journal of Clinical Pharmacology·U JeppesenK Brøsen
Jan 1, 1997·Pharmacology & Therapeutics·L S Kaminsky, Z Y Zhang

❮ Previous
Next ❯

Citations

Feb 22, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Siamak Cyrus KhojastehAnthony Y H Lu
Nov 1, 2003·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·D J CordatoG K Herkes
Mar 26, 2004·Transplantation Proceedings·M H KapturczakB Kaplan
Jun 8, 2002·Toxicology Letters·Marcello Lotti
Feb 13, 2001·Journal of Veterinary Pharmacology and Therapeutics·S A SmithL C Freeman
Jul 22, 2008·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Sang-Hun LeeByung-Cheol Lee
Oct 8, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Matthew HutzlerTimothy S Tracy
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Ji-Young ParkSu-Lyun Kim
Feb 8, 2002·Journal of Clinical Pharmacology·Paul R Casner, Eduardo Sandoval
Dec 17, 2008·Hematology·Charles W Francis
Oct 6, 2005·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Toshiro NiwaAkira Takagi
Dec 22, 1999·Pharmacotherapy·J M KolesarJ H Schiller
Jan 17, 2002·Pharmacotherapy·Aharon BlochYoseph Caraco
Jan 3, 2012·Advances in Nutrition·Sarah Egert, Gerald Rimbach
Jun 26, 2009·Journal of Clinical Pharmacology·Jack AnsellDavid J Greenblatt
Oct 5, 2011·Biopharmaceutics & Drug Disposition·Rostislav VečeřaPavel Anzenbacher
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Aug 26, 1999·Drug Metabolism Reviews·M Strolin Benedetti, M Bani
Jan 14, 2005·Journal of Clinical Pharmacology·David J Greenblatt, Lisa L von Moltke
Jan 25, 2006·Journal of Clinical Pharmacology·David J GreenblattPeter Goldman
Mar 6, 2012·Expert Opinion on Drug Metabolism & Toxicology·Justin D Lutz, Nina Isoherranen
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Ann K Daly, Barry P King
Mar 19, 2008·Expert Opinion on Pharmacotherapy·Stephen E Kimmel
Mar 1, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Alice ZachařováRostislav Večeřa
May 12, 2009·Drug Metabolism and Pharmacokinetics·Tae InoueShigeru Ohta
Jul 9, 2010·Drug Metabolism and Pharmacokinetics·Hidetaka KamimuraTakashi Usui
Mar 25, 2015·Biochemical Pharmacology·Masahiro UtohHiroshi Yamazaki
Oct 9, 2012·Biochemical Pharmacology·Yoshio HosoiHiroshi Yamazaki
Apr 22, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shotaro UeharaHiroshi Yamazaki
Oct 26, 2001·The Annals of Pharmacotherapy·J D Bair, T F Oppelt
Oct 26, 2001·The Annals of Pharmacotherapy·A Y LamM A Mohutsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.